KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Current Leases: 2009-2018

Historic Current Leases for Charles River Laboratories International (CRL) over the last 2 years, with Dec 2018 value amounting to $3.2 million.

  • Charles River Laboratories International's Current Leases was N/A to $3.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2018, which is N/A change from last year.
  • Latest data reveals that Charles River Laboratories International reported Current Leases of $3.2 million as of FY2018, which was down 99.99% from $23.9 billion recorded in FY2009.
  • In the past 5 years, Charles River Laboratories International's Current Leases registered a high of $3.2 million during FY2018, and its lowest value of $3.2 million during FY2018.
  • Its 1-year average for Current Leases is $3.2 million, with a median of $3.2 million in 2018.